Veracyte Inc Forecast, price target & analysts
Veracyte Inc Target price 2026 - Analyst rating & recommendation
Veracyte Inc Classifications & Recommendation
Veracyte Inc Price Target
| Target Price | $60.18 |
| Price | $45.81 |
| Potential |
31.37%
register free of charge
|
| Number of Estimates | 14 |
|
14 Analysts have issued a price target Veracyte Inc 2027 .
The average Veracyte Inc target price is $60.18.
This is
31.37%
register free of charge
$73.50
60.45%
register free of charge
$44.44
2.99%
register free of charge
|
|
| A rating was issued by 19 analysts: 16 Analysts recommend Veracyte Inc to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Veracyte Inc stock has an average upside potential 2027 of
31.37%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 517.15 | 604.37 |
| 16.02% | 16.87% | |
| EBITDA Margin | 16.67% | 27.40% |
| 163.63% | 64.40% | |
| Net Margin | 12.83% | 25.86% |
| 136.91% | 101.56% |
15 Analysts have issued a sales forecast Veracyte Inc 2026 . The average Veracyte Inc sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Veracyte Inc EBITDA forecast 2026. The average Veracyte Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Veracyte Inc Analysts have issued a net profit forecast 2026. The average Veracyte Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2031
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.82 | 1.94 |
| 164.52% | 136.59% | |
| P/E | 23.55 | |
| EV/Sales | 5.29 |
15 Analysts have issued a Veracyte Inc forecast for earnings per share. The average Veracyte Inc EPS is
This results in the following potential growth metrics and future valuations:
Current Veracyte Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Freedom Capital Markets |
Locked
➜
Locked
|
Locked | Sep 15 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Stephens & Co. |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Aug 03 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Freedom Capital Markets:
Locked
➜
Locked
|
Sep 15 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Stephens & Co.:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Aug 03 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Jul 31 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
